Hospital Acquired Infection (HAI) Control Market Size Worth USD 33.49 Billion in 2030 | Emergen Research

VANCOUVER, BC, Feb. 27, 2023 /PRNewswire/ -- The Hospital Acquired Infection Control Market size was valued at USD 29.13 Billion in 2021 and is projected to grow at a CAGR of 1.5% during the forecast period, according to a recent analysis by Emergen Research. The rising prevalence of hospital-acquired infections (HAIs), growing awareness regarding infection control measures, and advancements in technologies are the major factors driving the growth of the global hospital acquired infection control market.

HAIs are a major cause of morbidity and mortality worldwide and are associated with a substantial economic burden. According to the Centers for Disease Control and Prevention (CDC), around 1 in 31 hospitalized patients in the United States contracts an HAI, leading to an estimated 99,000 deaths annually. The World Health Organization (WHO) estimates that HAIs affect hundreds of millions of patients worldwide each year, resulting in millions of deaths and substantial financial costs to healthcare systems.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1575

The increasing focus on infection control measures is driving the growth of the hospital acquired infection control market. Governments and healthcare organizations worldwide are implementing strict regulations and guidelines to prevent and control the spread of HAIs. In addition, the increasing adoption of advanced technologies such as sterilization equipment, disinfectants, and UV-C light for infection control is also contributing to the growth of the market.

Drivers:

The rising prevalence of HAIs is the primary driver of the hospital acquired infection control market. According to the CDC, approximately 1.7 million HAIs occur in US hospitals each year, resulting in an estimated 99,000 deaths and an economic burden of up to USD 45 billion. Similarly, the WHO estimates that HAIs affect hundreds of millions of patients worldwide each year, resulting in millions of deaths and substantial financial costs to healthcare systems.

Governments and healthcare organizations worldwide are implementing strict regulations and guidelines to prevent and control the spread of HAIs. For instance, in the United States, the Centers for Medicare & Medicaid Services (CMS) has implemented regulations requiring hospitals to report HAIs and implement infection control measures to receive full reimbursement. Similarly, the World Health Organization (WHO) has developed guidelines and tools for the prevention and control of HAIs in healthcare settings.

Advancements in technologies for infection control are also driving the growth of the market. For instance, UV-C light is an effective method for disinfecting surfaces and reducing the spread of HAIs. In addition, the use of sterilization equipment and disinfectants has been shown to reduce the incidence of HAIs.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1575

Restraints:

One of the major restraints of the hospital acquired infection control market is the high cost associated with implementing infection control measures. Advanced technologies and equipment for infection control can be expensive, making it difficult for healthcare organizations, particularly in low- and middle-income countries, to implement these measures.

In addition, the lack of awareness and training regarding infection control among healthcare workers is also a significant restraint. Healthcare workers play a crucial role in preventing and controlling HAIs, but the lack of proper training and awareness can lead to the spread of infections.

Growth Projections:

The hospital acquired infection control market is expected to grow at a steady pace during the forecast period, driven by increasing government initiatives and growing awareness about the importance of infection control measures. According to Emergen Research, the global hospital acquired infection control market size was valued at USD 29.13 Billion in 2021 and is expected to expand at a CAGR of 1.5% from 2021 to 2030. The report also highlights the increasing demand for disinfection products and services, as well as the rising adoption of advanced technologies for infection prevention and control.

Current Trends and Innovations:

One of the key trends in the hospital acquired infection control market is the increasing adoption of ultraviolet (UV) disinfection technology for environmental cleaning. UV-C light is known to be effective against a wide range of pathogens, including bacteria, viruses, and fungi, and has been shown to reduce the risk of hospital acquired infections. Many hospitals and healthcare facilities are now investing in UV-C disinfection systems to complement their existing infection control protocols. For instance, in May 2021, Blue Ocean Robotics, a Danish robotics company, launched the UVD Robot, an autonomous UV-C disinfection robot that can move around and disinfect patient rooms and operating theatres.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/hospital-acquired-infection-control-market

Strategic Initiatives:

Key players operating in the hospital acquired infection control market include companies like 3M Company, Becton, Dickinson and Company, Belimed, Cantel Medical Corp., Ecolab, Inc., and STERIS Corporation. These companies are focusing on strategic initiatives such as product launches, mergers and acquisitions, and collaborations to strengthen their market position and expand their product portfolio.

For instance, in July 2021, STERIS Corporation announced the acquisition of Key Surgical, a leading supplier of sterile processing, operating room, and endoscopy products, to strengthen its portfolio of infection prevention and surgical solutions. Similarly, in June 2021, Ecolab, Inc. announced the launch of the Life Sciences Cleanroom Program, a comprehensive suite of cleaning, disinfection, and contamination control solutions designed for cleanroom environments in the pharmaceutical, biotech, and medical device industries.

Scope of Research

Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/1575

Emergen Research has segmented the global hospital acquired infection control market based on products & services, end-use, and region:

• Products & Services Outlook (Revenue, USD Billion; 2019–2030)
• Protective Barrier
• Sterilization
• Sterilization Equipment
• Sterilization Services
• Sterilization Consumables and Accessories

•  
• Disinfectants
• Hand Disinfectants
• Surface Disinfectants
• Skin Disinfectants
• Instrument Disinfectants

• Disinfectors
• Endoscope Reprocessing Products
• Others

• End-Use Outlook (Revenue, USD Billion; 2019–2030)
• Hospitals & ICUs
• Ambulatory Surgical & Diagnostic Centers
• Nursing Homes & Maternity Centers

• Regional Outlook (Revenue, USD Billion; 2019-2030)
• North America
• U.S.
• Canada
• Mexico

•  
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Sweden
• BENELUX
• Rest of Europe

•  
• Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of APAC

•  
• Latin America
• Brazil
• Rest of LATAM

•  
• Middle East & Africa
• Saudi Arabia
• UAE
• South Africa
• Israel
• Rest of Middle East & Africa

Latest Research Reports Published by Emergen Research:

Network Engineering Services Market, By Service Type (Network Assessment and Network Deployment), By Organization Size (Small & Medium Enterprises and Large Enterprises) and By End-Use (BFSI Telecom and Healthcare), By Region Forecast to 2030

Operational Technology Market, By Component (Field Instruments and Control System), By Networking Technology (Wired, and Wireless), By Industry (Process Industry, Discrete Industry, and Others), and By Region Forecast to 2030

Medical Devices Batteries Market, by Product Type (Implantable and Non-Implantable Batteries), by Battery Type, by End User, and By Region Forecast to 2030

Clustered Regularly Interspaced Short Palindromic Repeats Technology Devices Market, By Product & Service (Kits & Enzymes, Libraries, Cell Line Engineering, and gRNA Design), By Application(Biomedical and Agricultural), By End-Use, and By Region Forecast to 2030

Pediatric Oncology Market, By Indication (Leukemia and Neuroblastoma), By Treatment (Chemotherapy and Radiotherapy), By End-Use (Hospitals and Cancer & Radiation Therapy Centers), and By Region Forecast to 2030

Cardiogenic Shock Market, By Treatment Type (Drugs, Devices, and In-Vitro Test Kits), By End-Use (Hospitals, Ambulatory Surgical Centers, and Others), and By Region Forecast to 2030

Subscriber Identity Module Cards Market, By Type, By Application (Mobile Phone, Tablet, Wearable Device, and Others), By SIM Memory, and By Region Forecast to 2030

Smoke Detector Market By Power Source (Battery-powered and Hardwired), By Product Type (Photoelectric Smoke Detectors, Ionization Smoke Detectors, and Others), By Service, By End-use, and By Region Forecast to 2030

About Emergen Research 

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend's existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee 
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com 
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations  
Visit for More Insights: https://www.emergenresearch.com/insights  
Explore Our Custom Intelligence services | Growth Consulting Services  
Read our Press Release @ https://www.emergenresearch.com/press-release/global-hospital-acquired-infection-control-market  
Trending Titles LiDAR Market | Metaverse Market

Logo: https://mma.prnewswire.com/media/1579538/Emergen_Research_Logo.jpg